June 3 (Reuters) - Taysha Gene Therapies Inc TSHA.O:
TAYSHA GENE THERAPIES ANNOUNCES DETAILS FOR ORAL PRESENTATIONS AT THE 2025 IRSF RETT SYNDROME SCIENTIFIC MEETING REVIEWING RECENT UPDATES FROM THE TSHA-102 CLINICAL PROGRAM
Source text: ID:nGNX8tqSmK
Further company coverage: TSHA.O
((Reuters.Briefs@thomsonreuters.com;))